Literature DB >> 9486830

Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas.

M D Krieger1, I Gonzalez-Gomez, M L Levy, J G McComb.   

Abstract

Thirty-six cases of pilocytic astrocytomas treated at the Childrens Hospital of Los Angeles from 1984 through 1995 were reviewed. The mean age at initial presentation was 8 years (range 15 months to 14 years). These patients were followed for an average of 5.5 years. No patient was given chemotherapy or radiation therapy after the initial surgery for pilocytic astrocytoma. Twenty-three patients (64%) had a gross total resection with no residual tumor on immediate postoperative imaging studies. Three of these children had tumor recurrences 2-5 years after their initial surgery, requiring re-excision of their tumors. All 3 patients are subsequently tumor-free, with follow-up ranging from 4 to 10 years. In 4 patients with residual tumor involving the brainstem, there has been neither imaging evidence of tumor enlargement nor progression of clinical findings at 2.5, 4, 6 and 6 years, respectively. Nine of the 13 patients with residual tumor underwent re-excision, either for progression of symptoms or documented tumor growth on imaging studies. The second operation was undertaken an average of 1 year (range 1 month to 6 years) after the first. In 4 of these children (11% of our whole series), the recurrent tumor was classified as anaplastic astrocytoma. Three of these 4 children received radiation and/or chemotherapy, with only 1 patient showing disease progression in the follow-up period. Repeat blinded histopathological examination of these tumors confirmed both diagnoses. However, it was noted that 3 of the 4 pilocytic astrocytomas which subsequently showed anaplastic change initially displayed increased perivascular cellularity, while only 2 of the remaining 32 tumors exhibited this feature. These results encourage continued vigilance in the follow-up of pilocytic astrocytomas, and describe a histological feature which might indicate a more aggressive disease course.

Entities:  

Mesh:

Year:  1997        PMID: 9486830     DOI: 10.1159/000121218

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  22 in total

1.  True precocious puberty with vision loss.

Authors:  Vimal Upreti; Anil Bhansali; Kanchan K Mukherjee; Sambit Das; R Santosh; Pinaki Dutta; Rama Walia
Journal:  BMJ Case Rep       Date:  2009-12-03

2.  BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

Authors:  Matthew Mistry; Nataliya Zhukova; Daniele Merico; Patricia Rakopoulos; Rahul Krishnatry; Mary Shago; James Stavropoulos; Noa Alon; Jason D Pole; Peter N Ray; Vilma Navickiene; Joshua Mangerel; Marc Remke; Pawel Buczkowicz; Vijay Ramaswamy; Ana Guerreiro Stucklin; Martin Li; Edwin J Young; Cindy Zhang; Pedro Castelo-Branco; Doua Bakry; Suzanne Laughlin; Adam Shlien; Jennifer Chan; Keith L Ligon; James T Rutka; Peter B Dirks; Michael D Taylor; Mark Greenberg; David Malkin; Annie Huang; Eric Bouffet; Cynthia E Hawkins; Uri Tabori
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

3.  Supratentorial Pilocytic Astrocytoma Mimicking Convexity Meningioma with Early Anaplastic Transformation: A Case Report.

Authors:  Jung Hwan Lee; Soon Ki Sung; Chang Hwa Choi
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

4.  Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging.

Authors:  Albert H Kim; Elizabeth A Thompson; Lance S Governale; Catalina Santa; Kevin Cahll; Mark W Kieran; Susan N Chi; Nicole J Ullrich; R Michael Scott; Liliana C Goumnerova
Journal:  J Neurosurg Pediatr       Date:  2014-07-25       Impact factor: 2.375

5.  Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.

Authors:  Santhosh A Upadhyaya; Yahya Ghazwani; Shengjie Wu; Alberto Broniscer; Fredrick A Boop; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Pediatr Blood Cancer       Date:  2017-07-14       Impact factor: 3.167

Review 6.  Evidence-Based Practice: Temozolomide Beyond Glioblastoma.

Authors:  Jason Chua; Elizabeth Nafziger; Denise Leung
Journal:  Curr Oncol Rep       Date:  2019-03-05       Impact factor: 5.075

7.  Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.

Authors:  Karl Roessler; Alexander Bertalanffy; Hussun Jezan; Achmed Ba-Ssalamah; Irene Slavc; Thomas Czech; Herbert Budka
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

8.  Pilocytic astrocytoma with anaplastic features presenting good long-term clinical course after surgery alone: a case report.

Authors:  Katsuya Saito; Masahiro Toda; Kazunari Yoshida
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

9.  Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.

Authors:  Nicola Potter; Aikaterini Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic N P Thompson; Thomas S Jacques; Brian Harding; David G T Thomas; Rodger W Palmer; Jeremy Rees; John Darling; Tracy J Warr
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

10.  MR imaging characteristics of pilomyxoid astrocytomas.

Authors:  Atilla Arslanoglu; Bayram Cirak; Alena Horska; James Okoh; Tarik Tihan; Leslie Aronson; Anthony M Avellino; Peter C Burger; David M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.